ANGPTL4 and obstructive sleep apnea syndrome: We therefore made OSA stable transfectants over-expressing ANGPTL4 (OSA-A4), which showed 90-fold over-expression of ANGPTL4 (126.8 ng/105 cells) compared to control cells (OSA-EV; 1.4 ng/105 cells).